Your blog category
Picture this: you’re on a rollercoaster, the first big drop just hit, and your stomach flips. That’s exactly how Indian traders felt today as Nifty and Bank Nifty both lost ground after five straight sessions of weakness. Add to that a surprise twist — Donald Trump’s 100% tariff threat on pharma imports — and you […]
Saatvik Green Energy IPO debuts flat at ₹465, but strong fundamentals, expansion plans, and solar growth potential make it a stock worth tracking. Imagine waiting weeks for your favorite cricket match, only for the first over to end with dot balls. No sixes, no fours — just calm, steady play. That’s exactly how the Saatvik
IBPS PO Prelims Result 2025 out! Check direct link, cut off, scorecard details, and what’s next for the October 12 mains exam. If you’ve appeared for the IBPS PO Prelims 2025, chances are you’ve been refreshing the official website every few hours, waiting for the results. The anxiety is real — because this exam isn’t
Jinkushal Industries IPO: Check GMP, subscription status, price band, strengths, risks, and expert views to decide whether to invest for listing gains or long term. If you’ve been tracking IPO news lately, you’ve probably heard about Jinkushal Industries IPO. The buzz is real — the issue got fully subscribed on Day 1 itself and has
Why is TCS share price falling? Explore the real reasons behind TCS’s decline, from FII selling to sector weakness, and what it means for investors. If you’ve been tracking the stock market lately, one question might be nagging you: Why is TCS share price falling so sharply despite being India’s most trusted IT giant? For
Accenture layoffs 2025: Over 11,000 employees let go amid AI restructuring. Explore reasons, impact, and what it means for India’s IT future. Imagine this: You’ve worked for years at one of the biggest IT consulting firms in the world. Suddenly, one morning, you receive an email saying your role no longer exists. Why? Because artificial
Explore how Trump’s 100% pharma tariff affects Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s, with key insights for investors. Imagine you’re running a business where nearly half your revenue comes from one foreign market, and suddenly, overnight, a 100% tax is slapped on your products. That’s exactly the situation Indian pharmaceutical companies
Explore the implications of President Trump’s 100% tariff on branded drugs for Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s. In a bold move that has sent ripples through the global pharmaceutical industry, President Donald Trump announced a 100% tariff on imported branded and patented drugs, effective October 1, 2025. This decision has
CBDT extends income tax audit deadline to October 31, 2025. Learn who must file, updated Form 3CD rules, and how to avoid penalties. Tax season is always stressful for businesses and professionals, and this year is no different. If you’re running a business or practicing as a professional in India, you must pay attention to
The Nifty 50 and Sensex closed sharply lower, witnessing heavy selling in the last hour of trade. Get the latest updates on the Indian stock market, including Nifty levels, top losers, and sectoral performance.